Evidence for Three Subgroups of Female FMR1 Premutation Carriers Defined by Distinct Neuropsychiatric Features: A Pilot Study
Open Access
- 3 January 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Integrative Neuroscience
- Vol. 15, 797546
Abstract
Over 200 Cytosine-guanine-guanine (CGG) trinucleotide repeats in the 5′ untranslated region of the Fragile X mental retardation 1 (FMR1) gene results in a “full mutation,” clinically Fragile X Syndrome (FXS), whereas 55 – 200 repeats result in a “premutation.”FMR1premutation carriers (PMC) are at an increased risk for a range of psychiatric, neurocognitive, and physical conditions. Few studies have examined the variable expression of neuropsychiatric features in female PMCs, and whether heterogeneous presentation among female PMCs may reflect differential presentation of features in unique subgroups. In the current pilot study, we examined 41 female PMCs (ages 17–78 years) and 15 age-, sex-, and IQ-matched typically developing controls (TDC) across a battery of self-report, eye tracking, expressive language, neurocognitive, and resting state EEG measures to determine the feasibility of identifying discrete clusters. Secondly, we sought to identify the key features that distinguished these clusters of female PMCs. We found a three cluster solution usingk-means clustering. Cluster 1 represented a psychiatric feature group (27% of our sample); cluster 2 represented a group with executive dysfunction and elevated high frequency neural oscillatory activity (32%); and cluster 3 represented a relatively unaffected group (41%). Our findings indicate the feasibility of using a data-driven approach to identify naturally occurring clusters in female PMCs using a multi-method assessment battery. CGG repeat count and its association with neuropsychiatric features differ across clusters. Together, our findings provide important insight into potential diverging pathophysiological mechanisms and risk factors for each female PMC cluster, which may ultimately help provide novel and individualized targets for treatment options.Keywords
Funding Information
- National Institute of Child Health and Human Development (K23HD101416, U54HD082008, U54HD104461)
This publication has 87 references indexed in Scilit:
- Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndromeNature Neuroscience, 2012
- Young adult female fragile X premutation carriers show age- and genetically-modulated cognitive impairmentsBrain and Cognition, 2011
- CGG-repeat length threshold for FMR1 RNA pathogenesis in a cellular model for FXTASHuman Molecular Genetics, 2011
- Reliability of Eye Tracking and Pupillometry Measures in Individuals with Fragile X SyndromeJournal of Autism and Developmental Disorders, 2011
- Brief Report: Visual Processing of Faces in Individuals with Fragile X Syndrome: An Eye Tracking StudyJournal of Autism and Developmental Disorders, 2009
- Trajectories and Predictors of the Development of Very Young Boys with Fragile X SyndromeJournal of Pediatric Psychology, 2008
- No Evidence for a Difference in Neuropsychological Profile among Carriers and Noncarriers of the FMR1 Premutation in Adults under the Age of 50The American Journal of Human Genetics, 2008
- FMR1 and the fragile X syndrome: Human genome epidemiology reviewGenetics in Medicine, 2001
- Absence of expression of the FMR-1 gene in fragile X syndromeCell, 1991
- Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndromeCell, 1991